中国一次性低剂量CT肺癌筛查的多中心前瞻性队列研究
该研究在中国12个城市开展多中心、基于人群的前瞻性队列研究,纳入40-74岁无症状无肺癌史个体,用性别特异性风险评分区分高低危,高危者受邀一次性LDCT。
核心结论
- 在中国大人群中,一次性LDCT筛查与肺癌死亡率和全因死亡率显著降低相关。
- 结果提示一次性LDCT筛查在医疗资源有限国家有应用前景。
研究设计与样本
- 多中心、基于人群的前瞻性队列研究,覆盖中国8省12市。
- 招募40-74岁无症状且无肺癌史的个体。
- 采用性别特异性风险评分将参与者分为高危和低危。
- 高危者受邀一次性LDCT,按是否扫描分为筛查组和非筛查组。
临床怎么用
- 在高危人群中可考虑一次性LDCT筛查以降低肺癌死亡风险。
- 需结合性别、年龄、吸烟状态和经济状况等亚组因素制定人群特异性筛查策略。
局限性
- 需要进一步研究探索性别、年龄、吸烟状态和经济状况等亚组的交互作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lung cancer is the leading cause of cancer death worldwide. Data on the effectiveness of one-off low-dose CT (LDCT) in reducing lung cancer mortality and all-cause mortality are needed to inform screening programmes in countries with limited medical resources. We aimed to evaluate the effectiveness of one-off LDCT screening in the early detection of lung cancer in China. METHODS: A multicentre, population-based, prospective cohort study was done in 12 cities of eight provinces across China, recruiting individuals aged 40-74 years who were asymptomatic for lung cancer with no lung cancer history. Participants were classified as at high risk or low risk of lung cancer using a sex-specific risk score that incorporated cigarette smoking, level of physical activity, occupational exposures, history of chronic respiratory diseases, family history of lung cancer, diet, and passive smoking (women only). Participants at high risk were invited for a one-off LDCT scan and were classified into screened and non-screened groups on the basis of whether or not they had the scan. Lung cancer incidence density, lung cancer mortality, and all-cause mortality were calculated for the screened and non-screened groups. The effectiveness of a one-off LDCT scan was evaluated by a comparison of the screened and non-screened groups in terms of lung cancer mortality and all-cause mortality in the period from cohort entry until administrative censoring (June 20, 2020). Inverse probability weighting was adopted to account for potential imbalanced factors between the two groups and Cox proportional hazards model was used to estimate the weighted associations between mortality and one-off LDCT scans. FINDINGS: Between Feb 19, 2013, and Oct 31, 2018, 1 032 639 individuals were assessed for eligibility. 1 016 740 participants were enrolled in the study, of whom 3581 had a lung cancer diagnosis after a median follow-up of 3·6 years (IQR 2·8-5·1). Among the 223 302 participants at high risk, 79 581 (35·6%) had an LDCT scan (screened group) and 143 721 (64·4%) did not (non-screened group). After inverse probability weighting, lung cancer incidence density was 47·0% higher (hazard ratio 1·47 [95% CI 1·27-1·70]; p<0·0001), lung cancer mortality was 31·0% lower (0·69 [95% CI 0·53-0·92]; p=0·010) and all-cause mortality was 32·0% lower (0·68 [0·57-0·82]; p<0·0001) for participants in the screened group compared with those in the non-screened group. INTERPRETATION: One-off LDCT screening was associated with significantly lower lung cancer mortality and all-cause mortality in a large population in China. Our results point to the promise of one-off LDCT screening in countries with limited medical resources. Further studies are needed to explore interactions by subgroup-including sex, age, smoking status, and economic status-to develop population-specific screening strategies. FUNDING: Ministry of Finance and National Health Commission of the People's Republic of China. TRANSLATION: For the Chinese translation of the abstract see Supplementary Materials section.
引用
- Li N, Tan F, Chen W, et al. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study. Lancet Respir Med. 2022. PMID: 35276087. doi:10.1016/S2213-2600(21)00560-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。